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Background: The aim of this study was to compare the rates of local postoperative complications among
women undergoing modiﬁed radical mastectomy with an electric scalpel (ES) or a harmonic scalpel (HS).
It is thought that HS use has less postoperative complications, mainly seroma formation.
Methods: This study was a prospective non-randomised clinical trial (NCT01391988) among consecutive
patients, performed in parallel. Patients underwent modiﬁed radical mastectomy using an HS or ES. We
analysed the following operative variables: time, blood loss and seroma volume drainage. Postoperative
complications, including seroma, ﬂap necrosis, haematoma and infection were evaluated on the 7th and
14th days.
Results: Forty-six patients underwent a MRM with ES and 49 with HS; no differences were observed
between the groups. The rate of local complications was 29% in the HS group and 52% in the ES group
(p ¼ 0.024). The rates of seroma (16.3% versus 28.3%; p ¼ 0.161), necrosis (4.1% vs. 21.7%; p ¼ 0.013;
OR ¼ 0.15), haematoma (2.0% vs. 8.7%; p ¼ 0.195) and infection (2.0% vs. 6.5%; p ¼ 0.351) were lower in
the HS group. Adding the ﬁndings of all comparative studies using HSs in MRM to the seroma rates in the
current study, the seroma rate, expressed as a categorical variable, did not decrease with HS. Seroma was
present in 60/219 cases using an HS and in 69/239 cases utilising an ES (p¼ 0.72). Based on a multivariate
analysis, HS decreased the risk of skin necrosis (p ¼ 0.015).
Conclusions: HSs do not decrease the seroma rate. However, this method may be useful in skin sparing
mastectomy because it decreases skin ﬂap necrosis.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Breast cancer is a serious public health problem with high
incidence and prevalence coefﬁcients. Despite technological ad-
vances in surgery, seroma is the most common postoperative
complication following mastectomy, with rates ranging from 3% to
60%. However, the pathogenesis of breast cancer remains unclear.1,2
The use of an electric scalpel (ES) may increase the occurrence of
seroma in mastectomies because the thermal lesions in the skina, 1331. CEP: 14784-400, Bar-
anch 7009.
(R.A.C. Vieira).
ciates Ltd. Published by Elsevier Ltﬂaps may determine a local inﬂammatory reactions. 3,4 Other
postoperative complications of mastectomies occur at lower fre-
quencies and include skin ﬂap necrosis, infection and haema-
toma.5e7 These complications not only cause higher treatment
costs but also cause delays in starting subsequent oncological
therapies (chemotherapy and radiotherapy). Reducing the fre-
quency of these complications is also important within the current
practice of oncoplastic surgery, inwhich there is a constant concern
for aesthetic results in association with the concepts of oncological
surgery.8,9
Technologies that are supposed tobe less traumatic to the tissues,
such as the harmonic scalpel (HS), might reduce the rates of local
postoperative complications.10 Studies comparing complicationd. All rights reserved.
Fig. 1. Effects of scalpel-type during surgery in skin ﬂap and pectoral muscle. Electric
scalpel (A). Harmonic scalpel (B).
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with limited numbers of patients.
The objective of this study was to compare local postoperative
complications following modiﬁed radical mastectomy (MRM),
mainly seroma, according to the scalpel used for the dissection, that
is, either conventional ES or HS.
2. Materials and methods
2.1. Study population
This study was designed and evaluated in the Postgraduate Medical Biotech-
nology, Research and Development Programme, Botucatu Medical School, Julio de
Mesquita Filho University (UNESP), Brazil. Institutional Review Board approval was
obtained. This study was a pilot prospective non-randomised trial (www.
clinicaltrials.gov; NCT01391988) at the Barretos Cancer Hospital conducted be-
tween April and December 2008. The patients were women aged 18 years or older,
with breast carcinoma (ductal or lobular) of any stage and for whomMRM had been
recommended. Patients were excluded if they had blood dyscrasia, collagen dis-
eases, infections (mammary or axillary), ulcerated tumours, pregnancy or if with
they refused to participate in the protocol. Patients with no measurable drain vol-
ume were also excluded.
2.2. Study groups and endpoints
All patients received guidance and provided signed informed consent. We used
parallel assignment and consecutive selection by three surgeons, with patients
selected according to the scalpel to be used, either conventional ES or HS.
The patients underwent MRM (Patey or Madden),11 with level III axillary
dissection. Fig. 1 shows an example of the visual difference between the types of
scalpels. Three surgical oncologists with a minimum of 5 years of experience in
breast cancer surgery performed the procedures. The instruments used for the
surgery were either an ES, calibrated at 40 Watts of cutting and coagulation power
(S-501s model, made byWEM, Brazil), or an HS (Harmonicwith a GEN04 generator
from Ethicon Endo-surgery, Cincinnati, USA), calibrated at power levels 3 and 5
using the HP054 hand piece and HF105 curved blade. During the induction of
anaesthesia, all patients prophylactically received 2 g of cefazolin intravenously. The
surgical incision was closed with interrupted sutures of 4/0 nylon. In all of theTable 1
Mean, minimum and maximum values of clinical and treatment-related characteristics i
Variables Harmonic
Median
Group characteristics
Body mass index Kg/m2 26.1
Age Years 58.0
Breast weight Grams 717.0
Weight of axillary
lymphadenectomy product
Grams 75.0
Dissected lymph nodes Number 17.9
Compromised lymph nodes Number 7.3
Surgical results
Duration of surgery Minutes 90.0
Blood loss ml 235.0
TDV up to the 7th day after surgery ml 76.7
TDV ¼ Total drainage volume.operations, a continuous vacuum suction drainwith a 600 ml capacity PVC reservoir
was used. Two 4.8 mm calibre suction drains were placed in the surgical bed, and
occlusive dressings were placed over the surgical wounds for 24 h. Blood loss during
the operation was evaluated by weighing the sponges before (dry) and after use in
the surgery and recorded in grammes. The data were recorded in a standard form.
All patients were clinically discharged between 12 and 24 h postoperatively and
given medical guidance about caring for the surgical wound and handling the drain,
along with a card on which to note the daily drainage volume.
The patients returned to the hospital on the seventh postoperative day with the
recorded measurements of the daily drainage; the drainwas subsequently removed.
On the fourteenth post-operative day, all of the stitches were removed. The patients
with seroma accumulation were evacuated, the axilla was punctured and the vol-
ume was measured. A nurse who was blinded to the type of scalpel used in the
surgery assessed the complications. The local postoperative complications (necrosis
of the breast skin ﬂap, seroma, haematoma and infection of the surgical wound)
were evaluated at two time-points: on the seventh and fourteenth postoperative
days.2.3. Data analysis
Demographic, clinical, and treatment-related variables were recorded on a
standardised form. SPSS software version 15 (SPSS Inc., Chicago, IL, USA) was used
for statistical analysis. The study population was characterised using descriptive
statistics. As most of the quantitative variables did not adhere to the normal dis-
tribution curve according to the KolmogoroveSmirnov test, nonparametric tests
were chosen for analysis of the differences among these variables. Comparisons
between unpaired groups were carried out by means of ManneWhitney when the
variables were numerical. The chi-square test or Fisher’s exact test were used to
compare qualitative variables and risks. The risk was investigated using the odds
ratio (OR). We used a non-exploratory multivariate analysis model. The type of
scalpel was considered the variable of interest, body mass index and surgeon were
the mandatory adjustable variables, and HS was an independent protector factor of
ﬂap necrosis. The signiﬁcance level was set at 5%.3. Results
In total, 46 patients underwent anMRMwith ES and 49 with HS.
No statistically signiﬁcant differences between the two groups
were found regarding body mass index, age, breast weight, weight
of tissue from the axillary lymphadenectomy, or number of
dissected and metastatic lymph nodes. There were no differences
between the duration of surgery, blood loss, or drainage volume on
the seventh postoperative day (Table 1). The prevalence of diabetes
was similar between the two groups: 9% in the conventional ES
group and 6% in the HS group (p ¼ 0.706). These ﬁndings show that
the selection was adequate and that the groups were comparable.
The rate of local complications was 29% in the HS group and 52%
in the ES group (p ¼ 0.024). Necrosis was the only complication of
the four evaluated (seroma, ﬂap necrosis, infection and haema-
toma) that showed a signiﬁcant difference between the groups,
occurring less frequently in thewomen in the HS group (4% vs. 22%;
p ¼ 0.013). The frequencies of the other complications were alson relation to the type of scalpel used for dissection.
Electric p
Minemax Median Minemax
18.0e43.7 26.6 18.7e44.5 0.626
27e80 53.5 31e82 0.185
144.0e1624.0 737.5 110.0e2800.0 0.461
22.0e298.0 75.0 15.0e411.0 0.281
9.0e51.0 19.1 7.0e33.0 0.259
1.0e21.0 10.2 1.0e32.0 0.171
60.0e155.0 97.5 40.0e164.0 0.121
40.0e1019.0 189.5 36.0e589.0 0.102
18.3e316.6 98.5 31.6e292.2 0.187
Table 2
Number and percentage of local postoperative complications in relation to the type
of scalpel used for dissection.
Variables Category Harmonic Electric p (c2) OR
n % n %
Seroma No 41 83.7 33 71.7 0.161 2.02
Yes 8 16.3 13 28.3
Necrosis No 47 95.9 36 78.3 0.013 6.53
Yes 2 4.1 10 21.7
Infection No 48 98.0 43 93.5 0.351 3.35
Yes 1 2.0 3 6.5
Haematoma No 48 98.0 42 91.3 0.195 4.57
Yes 1 2.0 4 8.7
OR ¼ Odds ratio.
Table 4
Non-exploratory multivariate analysis, with the scalpel type as the variable of
interest.
Variable Category N Or 95%CI p Value
Type of scalpel Harmonic 49 1.0 Reference
Electric 46 7.4 1.5e37.4 0.015
Body mass index 30 kg/m2 67 1.0 Reference
>30 kg/m2 28 3.1 0.8e11.8 0.101
Surgeon 2 þ 3 25 1.0 Reference
1 70 6.6 0.7e58.3 0.089
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signiﬁcant (Table 2).
The primary surgeon performed 73.7% of the surgeries. There
were no statistically signiﬁcant differences between the primary
researcher and the other surgeons in terms of complications (42%
vs. 35%; p ¼ 0.539) and skin necrosis (15.7% vs. 4.0%; p ¼ 0.174).
There were no signiﬁcant differences between presence and
absence of necrosis in relation to duration of surgery (105 min vs.
90 min; p ¼ 0.160), age (58 years vs. 54 years; p¼ 0.243) and breast
weight (750 g vs. 720 g; p ¼ 0.726).
Tables 3 and 4 show the factors related to skin ﬂap necrosis in
univariate and multivariate analysis, respectively. The use of an HS
decreased the risk of ﬂap necrosis by approximately 86%
[OR ¼ 0.135; p ¼ 0.015; IC ¼ 0.027e0.683)].
4. Discussion
The use of electric scalpels in mastectomies began in the 1970s
and signiﬁcantly reduced the duration of surgery and the amount of
intraoperative blood loss.12e14 However, subsequent published
papers demonstrated an increase in complications related to the
surgical wound.12
The use of an ultrasonic HS began in the 1990s and has led to
improvements in several peri-operative outcomes.15 In breast sur-
gery, HSs have led to decreased blood loss, drainage output,
drainage duration and seroma formation,15 evaluated in eight
caseecontrol studies.13,16e21 Methodological differences were
observed in two of four non-randomised studies.13,16e18 One study
included patients inwhich the HSwas used only in the breast,14 andTable 3
Clinical characteristics and postoperative complications in relation to the occurrence
of skin ﬂap necrosis. Univariate analysis.
Variables Categories Flap necrosis p (c2) OR
Absent (%) Present (%)
Type of scalpel Harmonic 47 (95.9) 2 (4.1) 0.013 1.00
Electric 36 (78.3) 10 (21.7) 6.53
Body mass index Less or equal to 30 61 (91.0) 6 (9.0) 0.172 1.00
Greater than 30 22 (78.6) 6 (21.4) 2.77
Clinical stage 0 þ I þ II 32 (86.5) 5 (13.5) 1.000 1.00
III þ IV 51 (87.9) 7 (12.1) 0.88
Surgeon Primary 59 (84.3) 11 (15.7) 0.174 1.00
2 and 3 24 (96.0) 1 (4.0) 0.22
Diabetes Absent 76 (86.4) 12 (13.6) 0.590 e
Present 7 (100) 0
Neoadjuvant Present 44 (86.3) 7 (13.7) 0.767 1.00
Chemotherapy Absent 39 (88.6) 5 (11.4) 0.81
Seroma Absent 66 (89.2) 8 (10.8) 0.455 1.00
Present 17 (81.0) 4 (19.0) 1.94
Infection Absent 79 (86.8) 12 (13.2) 1.000 e
Present 4 (100.0) 0
OR ¼ Odds Ratio.the other study analysed retrospective data.13 Of the four pro-
spective randomised studies,3,20e22 in one study, the groups were
not presented,21 and in the other studies, the patients underwent
different surgeries, i.e., patients with MRM were analysed in
conjunction with simple mastectomy,3 quadrantectomy23 or skin
sparing mastectomy.22 Another difference observed in the publi-
cations is related to the axillary surgery. These studies included
axillary lymphadenectomy (level II18, 23 or level III10,21) or sentinel
lymph node dissection.22 These differences can lead to different
conclusions. Table 5 reviews the current literature related to the use
of the harmonic scalpel in mastectomy.3,10,13,16e18,20e24 Our study
represents the largest prospective case control study with the same
patient characteristics (Table 1), using the same type of surgery in
each group (MRM with level III dissection).
Although the frequencies of seroma, haematoma and infection
of surgical wounds in our series were lower in the group of women
who underwent surgery with HS, these differences were not sig-
niﬁcant, most likely because the number of women in each arm of
the study was insufﬁcient. Based on the prevalence of the seroma
rate observed in our study, approximately 186 women are neces-
sary in each arm to establish of an alpha error of 5% and a beta error
of 20%. This ﬁnding shows that there is a need to develop multi-
centre studies to compare the local postoperative complications in
relation to the technology used for tissue dissection.
Barretos Cancer Hospital is a public hospital in which patients
are frequently low-income and have a low education level. Despite
being instructed to note the drain volume, a number of patients did
not follow the instructions correctly and were excluded from the
analysis because seroma was initially considered to be the main
endpoint. Seroma is the most frequent complication after MRM.25
The incidence decreases with the following factors: breast conser-
vation,4 neoadjuvant chemotherapy,4 surgeon technique,4 cold
scalpel,26 young age,27 non-smoker26 and healthy BMI.20 Porter was
the ﬁrst to describe a signiﬁcant decrease in seroma rate with HS.3
Lumachi,20 in a study using multivariate analysis, found that the
total number of nodes removed, presence of positive nodes, and the
use of HSs decreased seroma drainage. Previous studies used
different criteria to determine when to remove the drain, either
removing it after the 4th day postoperative17,22 or when the volume
was approximately 20e100 ml at 24 h.3,16,18 Methods of seroma
assessment have differed among studies evaluating seroma
rate,13,16,17,21 total drainage, or time of drain removal.3,18,22,23 When
HSs were used, studies reported a decrease in the total volume of
drainage,3,16,21e23 decreased drainage time,3,16,23 increased in
seroma volume,18 and similar seroma prevalence.13,16,17,21 This
study showed a similar seroma rate. Different criteria for drain
removal and evaluation of seroma might produce different results.
Adding the ﬁndings of all comparative studies referencing seroma
rate using HSs in MRM13,16,17,21 to the current study, when seroma
was expressed as a categorical variable, seroma was present in 60/
219 cases utilising an HS and in 69/239 cases using an ES (p¼ 0.72).
Therefore, the HS does not appear to decrease seroma rate in MRM,
but prospective controlled studies are necessary to answer this
question deﬁnitively.
Table 5
Studies using harmonic scalpel in mastectomy.
Author Year Type of study Surgery No harmonicc No electricc Total No of PO complicationsb Signiﬁcant difference (harmonic)
Kurtz13 1995 Rt, NR, CCS MRM 86 110 196 14 infection, 14 wound dehiscence More blood loss
Porter3 1998 P, Rz, CCS MRM or
SM
38/29c 42/30c e 4 cases of infecton, 1 haematoma, 7 skin
necrosis
More blood loss, decrease seroma rate
Deoa,10 2000 Case reports MRM 14 e 14 No haematoma or ﬂap necrosis Learning curve reduce complications
Deo16 2002 NR, CCS MRM 23 23 46 No infection ﬂap necrosis or haematoma Lower blood loss, drainage volume,
drain days. Similar seroma rate
Galatius17 2003 P, NR, CCS MRM 30 29 59 1 case of haematoma, 1 infection, 2 necrosis Similar results
Lumachi20 2004 P, Rz, CCS MRM and
BCS
45 47 92 No infection ﬂap necrosis or wound infection Seroma related to BMI, tumour size,
nodes removed. Similar seroma rate
Lumachi23 2004 P, Rz, CCS MRM and
BCS
38/18c 38/18c e Not related Seroma related to no of node removed,
positive node and type scalpel.
Mastectomy increase seroma rate
Adwani18 2006 P, NR, CCS MRM 13 29 42 Complication in scalpel: 2 infection and
1 skin necrosis
Lower blood loss
Kontos22 2008 P, Rz, CCS MRM, SM,
BCS
48/8c 60/11c e Not speciﬁed complications in relation
to type of surgery
No difference between the groups. One
case of skin necrosis in the EC group
Poolea,24 2010 Case report MRM 1 e 1 e Feasibility with cardiac pacemarker
Kozomara21 2010 P, Rz, CCS MRM 31 30 61 4 cases of infection, 1 wound dehiscence Lower blood loss
Ribeiro Current P, NR, CCS MRM 49 46 95 4 cases of infection, 5 haematoma, 12 skin
necrosis
Lower skin necrosis; similar seroma rate
CCS ¼ Case control study; NR ¼ non randomized; Rz ¼ Randomized; P ¼ prospective; Rt ¼ retrospective; MRM ¼ modiﬁed radical mastectomy; BCS ¼ breast conservative
surgery; SM ¼ simple mastectomy; PO ¼ post-operative.
a Cases excluded in total evaluation.
b Excluded seroma.
c MRM.
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patients, infection in 4%, and necrosis in 13%; these numbers are
similar to other studies.25 The overall rate of postoperative com-
plications was not different between surgeons (p ¼ 0.539). This
ﬁnding was also observed within speciﬁc complications, including
haematoma (p ¼ 1.000), infection (p ¼ 0.282), necrosis (p ¼ 0.174)
and seroma (p ¼ 0.260). Moreover, evaluations on the seventh and
fourteenth postoperative days were blinded to the surgeon. The
nurse dealing with the complications was unaware of the identities
of the groups, and a graduated score for the necrosis (partial ﬂap,
epidermolysis and eschar formation)28 was not used. Medical re-
cords data show that there were three epidermolyses, eight small
skin necroses and one large skin necrosis.
In the literature, the rates of ﬂap necrosis in MRM vary from 5%
to 61%.25,29,30 Adwani described one case of skin necrosis in the ES
group in his study,18 while in the other studies, there was no
reference to skin necrosis. This reduction can be explained in terms
of the temperatures attained: HSs reach lower temperatures
(approximately 80 C) than ESs (up to 400 C). This lower tem-
perature promotes a more precise dissection with less severe
thermal lesions. Although our skin necrosis rate may be considered
high, it is consistent with the current literature related to skin ne-
crosis in mastectomy,5,25 with full-thickness losses occurring in up
to 8% of the cases.5,25 Some of these differences are related to the
deﬁnition used for skin necrosis, which include epidermolysis,27
marginal necrosis,6 and partial5 or full-thickness losses.5,25 In our
prospective study, the nurse did not quantify the skin necrosis, a
fact that can maximise the actual clinical necrosis results because
only one patient had large skin necrosis and three patients needed
extensive curative surgery. In addition to our skin necrosis, adding
these ﬁndings to all studies using an HS in MRM,16e18,20,21 skin
necrosis was present in 4/191 cases with an HS and in 11/204 cases
with an ES (p ¼ 0.12). Now that we are performing more skin
sparing mastectomies, it is imperative to improve the quality of
breast reconstruction procedures by avoiding post-operative com-
plications such as infection and skin ﬂap necrosis, as these condi-
tions are related to implant loss.31,32 We must, therefore, consider
the oncologic principles associated with a high implant success
rate. Skin thickness is associated with a low rate of skin necrosis,and an HS should be considered for this type of surgery. More
studies are necessary to prove the beneﬁt of HSs for this procedure.5. Conclusions
The present study shows that HSs do not decrease seroma rate
in MRM. Necrosis of the breast skin ﬂaps were less prevalent in the
group undergoing surgery using the harmonic scalpel. However,
because HSs reduce the rate of local complications after MRM, it is
possible that tissue dissection using this device may yield better
aesthetic results without going against oncological principles.
Nevertheless, additional prospective studies, such as the one
described here but with larger patient samples, are needed to verify
this assertion.
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